Oral sensory stimulation improves glucose tolerance in humans: effects on insulin, C-peptide, and glucagon - PubMed (original) (raw)
Oral sensory stimulation improves glucose tolerance in humans: effects on insulin, C-peptide, and glucagon
K L Teff et al. Am J Physiol. 1996 Jun.
Abstract
In animals, bypassing the oropharyngeal receptors by intragastric administration of glucose results in glucose intolerance. To determine whether the absence of oral sensory stimulation alters glucose tolerance in humans, we monitored plasma levels of glucose and hormones after intragastric administration of glucose, with and without subjects tasting food. Plasma glucose area under the curve (AUC) was significantly lower after oral sensory stimulation (3,433 +/- 783 vs. 5,643 +/- 1,397 mg.dl-1. 195 min-1; P < 0.03; n = 8). Insulin and C-peptide AUCs were higher during the first one-half of the sampling period (insulin, 5,771 +/- 910 vs. 4,295 +/- 712 microU. ml-1.75 min-1; P < 0.05; C-peptide, 86 +/- 10 vs. 66 +/- 9 ng.ml-1. 75 min-1; P < 0.03) and lower during the second one-half of the sampling period compared with the control condition (1,010 +/- 233 vs. 2,106 microU.ml-1. 120 min-1; P < 0.025; 31 +/- 8 vs. 56 +/- 18 ng.ml-1. 120 min-1; P < 0.05; insulin and C-peptide, respectively). Oral sensory stimulation markedly increased plasma glucagon compared with the control condition (1,258 +/- 621 vs. -2,181 +/- 522 pg.ml-1. 195 min-1; P < 0.002). These data provide evidence in humans that oral sensory stimulation influences glucose metabolism and suggest that the mechanisms elicited by this cephalic stimulation are necessary for normal glucose homeostasis.
Similar articles
- Oral sensory stimulation in men: effects on insulin, C-peptide, and catecholamines.
Teff KL, Levin BE, Engelman K. Teff KL, et al. Am J Physiol. 1993 Dec;265(6 Pt 2):R1223-30. doi: 10.1152/ajpregu.1993.265.6.R1223. Am J Physiol. 1993. PMID: 8285261 - Ingestion of an exogenous ketone monoester improves the glycemic response during oral glucose tolerance test in individuals with impaired glucose tolerance: A cross-over randomized trial.
Nakagata T, Tamura Y, Kaga H, Sato M, Yamasaki N, Someya Y, Kadowaki S, Sugimoto D, Satoh H, Kawamori R, Watada H. Nakagata T, et al. J Diabetes Investig. 2021 May;12(5):756-762. doi: 10.1111/jdi.13423. Epub 2020 Nov 1. J Diabetes Investig. 2021. PMID: 33010116 Free PMC article. Clinical Trial. - Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects.
Hansen KB, Vilsbøll T, Bagger JI, Holst JJ, Knop FK. Hansen KB, et al. J Clin Endocrinol Metab. 2010 Jul;95(7):3309-17. doi: 10.1210/jc.2010-0119. Epub 2010 Apr 21. J Clin Endocrinol Metab. 2010. PMID: 20410219 - Postprandial glucose, insulin and incretin responses to different carbohydrate tolerance tests.
Deng Y, Zhang Y, Zheng S, Hong J, Wang C, Liu T, Sun Z, Gu W, Gu Y, Shi J, Yao S, Wang W, Ning G. Deng Y, et al. J Diabetes. 2015 Nov;7(6):820-9. doi: 10.1111/1753-0407.12245. Epub 2015 Mar 4. J Diabetes. 2015. PMID: 25395350 Clinical Trial. - Cephalic phase insulin release: A review of its mechanistic basis and variability in humans.
Pullicin AJ, Glendinning JI, Lim J. Pullicin AJ, et al. Physiol Behav. 2021 Oct 1;239:113514. doi: 10.1016/j.physbeh.2021.113514. Epub 2021 Jul 9. Physiol Behav. 2021. PMID: 34252401 Free PMC article. Review.
Cited by
- Mice Condition Cephalic-Phase Insulin Release to Flavors Associated with Postoral Actions of Concentrated Glucose.
Glendinning JI, Archambeau A, Brouwer LR, Dennis A, Georgiou K, Ivanov J, Vayntrub R, Sclafani A. Glendinning JI, et al. Nutrients. 2024 Jul 12;16(14):2250. doi: 10.3390/nu16142250. Nutrients. 2024. PMID: 39064693 Free PMC article. - Vagal activation alters prandial bile acid composition and glycemia in patients with hypoglycemia after Roux-en-Y gastric bypass surgery.
Honka H, Bhattacharjee J, Zadeh M, Kohli R, Gastaldelli A, Salehi M. Honka H, et al. Neurogastroenterol Motil. 2024 May;36(5):e14763. doi: 10.1111/nmo.14763. Epub 2024 Feb 11. Neurogastroenterol Motil. 2024. PMID: 38342974 - Sugar signals from oral glucose transporters elicit cephalic-phase insulin release in mice.
Takamori M, Mitoh Y, Horie K, Egusa M, Miyawaki T, Yoshida R. Takamori M, et al. J Physiol Sci. 2023 Jul 31;73(1):16. doi: 10.1186/s12576-023-00875-3. J Physiol Sci. 2023. PMID: 37525102 Free PMC article. - Bariatric Surgery Alters the Postprandial Recovery From Hypoglycemia, Mediated by Cholinergic Signal.
Salehi M, Tripathy D, Peterson R, Honka H, Pezzica S, DeFronzo R, Gastaldelli A. Salehi M, et al. Diabetes. 2023 Oct 1;72(10):1374-1383. doi: 10.2337/db23-0207. Diabetes. 2023. PMID: 37467435 Free PMC article. - The elusive cephalic phase insulin response: triggers, mechanisms, and functions.
Langhans W, Watts AG, Spector AC. Langhans W, et al. Physiol Rev. 2023 Apr 1;103(2):1423-1485. doi: 10.1152/physrev.00025.2022. Epub 2022 Nov 24. Physiol Rev. 2023. PMID: 36422994 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous